KUAISHOU-W (01024) announced on September 3 that it has invested approximately HKD 14.9687 million to repurchase 455,000 shares.
Kuaishou-W (01024) announced that on September 3, 2026, the company spent approximately HKD 14.9687 million to repurchase 455,000 shares, at a price ranging from HKD 32.7 to 33.02 per share.
KUAISHOU-W (01024) announced that on September 3, 2026, the company will spend approximately HKD 14,968,700 to repurchase 455,000 shares, with a repurchase price ranging from HKD 32.70 to HKD 33.02 per share.
Related Articles
SIMCERE PHARMA (02096): YingmuLe has been approved by the National Medical Products Administration for in China.
DL HOLDINGS GP (01709): Since the commencement of its Bitcoin mining operations, it has produced a total of 506.228 Bitcoins.
New IPO News | Shenzhen Salubris Pharmaceuticals (002294.SZ) has submitted another application to the Hong Kong Stock Exchange.
SIMCERE PHARMA (02096): YingmuLe has been approved by the National Medical Products Administration for in China.
DL HOLDINGS GP (01709): Since the commencement of its Bitcoin mining operations, it has produced a total of 506.228 Bitcoins.
New IPO News | Shenzhen Salubris Pharmaceuticals (002294.SZ) has submitted another application to the Hong Kong Stock Exchange.
RECOMMEND
